Intelligent Bio Solutions completes precision testing for FDA submission
Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced the completion of precision testing for its Intelligent Fingerprinting Drug Screening System, a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
